Considerations for Determining Pharmacy-Specific Hazardous Drugs

As of January 1, 2017, California law requires pharmacies compounding with anti-neoplastic agents as classified by National Institute for Occupational Safety and Health (NIOSH) do so within the proper facilities and engineering controls as defined in CCR §1735.6(e) and 1751.4. The law also requires any other drugs, compounds or materials to require these same conditions if determined hazardous by the PIC. Each pharmacy must review their operations to ensure they are meeting this new mandate to protect their employees and the public. This document contains considerations for determining if any other drugs outside of the NIOSH anti-neoplastic agents require the same compounding conditions. 

Click image to download PDF